WHO ICTRP trial
Prospective study on the efficacy of botulinum toxin A injection and deep brain…
ChiCTR-ONN-17013806 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONN-17013806 |
|---|---|
| Public title | Prospective study on the efficacy of botulinum toxin A injection and deep brain stimulation in the treatment of primary Meige syndrome |
| Scientific title | Prospective study on the efficacy of botulinum toxin A injection and deep brain stimulation in the treatment of primary Meige syndrome |
| Primary sponsor | Bei Jing Tong Ren hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Primary Meige syndrome |
| Interventions | treatment group:Deep brain stimulation;control group:Botulinum toxin type A injection |
| Registration date | Dec 10, 2017 |
| Target size | treatment group:50;control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: